Arteris Analyst Ratings
Arteris Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/13/2023 | 182.26% | Rosenblatt | → $21 | Reiterates | Buy → Buy |
| 09/06/2023 | 88.17% | Northland Capital Markets | $16 → $14 | Maintains | Outperform |
| 08/07/2023 | 182.26% | Rosenblatt | → $21 | Reiterates | Buy → Buy |
| 08/03/2023 | 182.26% | Rosenblatt | → $21 | Reiterates | Buy → Buy |
| 06/09/2023 | 182.26% | Rosenblatt | → $21 | Reiterates | Buy → Buy |
| 06/02/2023 | 115.05% | Northland Capital Markets | → $16 | Reiterates | → Outperform |
| 03/02/2023 | 34.41% | TD Cowen | $12 → $10 | Maintains | Outperform |
| 03/01/2023 | 115.05% | Northland Capital Markets | $20 → $16 | Maintains | Outperform |
| 03/01/2023 | 182.26% | Rosenblatt | → $21 | Reiterates | → Buy |
| 11/09/2022 | -5.91% | BMO Capital | $12 → $7 | Maintains | Market Perform |
| 08/10/2022 | 61.29% | BMO Capital | $15 → $12 | Maintains | Market Perform |
| 08/10/2022 | 182.26% | Rosenblatt | $35 → $21 | Maintains | Buy |
| 11/22/2021 | 222.58% | BMO Capital | → $24 | Initiates Coverage On | → Market Perform |
| 11/22/2021 | 343.55% | Jefferies | → $33 | Initiates Coverage On | → Buy |
| 11/22/2021 | 262.9% | Northland Capital Markets | → $27 | Initiates Coverage On | → Outperform |
| 11/22/2021 | 370.43% | Rosenblatt | → $35 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/13/2023 | 182.26% | 罗森布拉特 | →$21 | 重申 | 购买→购买 |
| 09/06/2023 | 88.17% | 北国资本市场 | $16→$14 | 维护 | 跑赢大盘 |
| 08/07/2023 | 182.26% | 罗森布拉特 | →$21 | 重申 | 购买→购买 |
| 08/03/2023 | 182.26% | 罗森布拉特 | →$21 | 重申 | 购买→购买 |
| 06/09/2023 | 182.26% | 罗森布拉特 | →$21 | 重申 | 购买→购买 |
| 06/02/2023 | 115.05% | 北国资本市场 | →$16 | 重申 | →跑赢大盘 |
| 03/02/2023 | 34.41% | TD Cowen | $12→$10 | 维护 | 跑赢大盘 |
| 03/01/2023 | 115.05% | 北国资本市场 | $20→$16 | 维护 | 跑赢大盘 |
| 03/01/2023 | 182.26% | 罗森布拉特 | →$21 | 重申 | →购买 |
| 11/09/2022 | -5.91% | 蒙特利尔银行资本 | $12→$7 | 维护 | 市场表现 |
| 2022年08月10日 | 61.29% | 蒙特利尔银行资本 | $15→$12 | 维护 | 市场表现 |
| 2022年08月10日 | 182.26% | 罗森布拉特 | $35→$21 | 维护 | 买 |
| 2021年11月22日 | 222.58% | 蒙特利尔银行资本 | →$24 | 开始承保 | →市场表现 |
| 2021年11月22日 | 343.55% | 杰富瑞 | →$33 | 开始承保 | →购买 |
| 2021年11月22日 | 262.9% | 北国资本市场 | →$27 | 开始承保 | →跑赢大盘 |
| 2021年11月22日 | 370.43% | 罗森布拉特 | →$35 | 开始承保 | →购买 |
What is the target price for Arteris (AIP)?
Arteris(AIP)的目标价是多少？
The latest price target for Arteris (NASDAQ: AIP) was reported by Rosenblatt on September 13, 2023. The analyst firm set a price target for $21.00 expecting AIP to rise to within 12 months (a possible 182.26% upside). 10 analyst firms have reported ratings in the last year.
罗森布拉特于2023年9月13日报道了Arteris(纳斯达克：AIP)的最新目标价。这家分析公司将目标价定为21美元，预计12个月内AIP将升至(可能上涨182.26%)。去年有10家分析公司公布了评级。
What is the most recent analyst rating for Arteris (AIP)?
分析师对Arteris(AIP)的最新评级是多少？
The latest analyst rating for Arteris (NASDAQ: AIP) was provided by Rosenblatt, and Arteris reiterated their buy rating.
分析师对Arteris(纳斯达克：AIP)的最新评级由罗森布拉特提供，Arteris重申其买入评级。
When is the next analyst rating going to be posted or updated for Arteris (AIP)?
Arteris(AIP)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arteris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arteris was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Arteris的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Arteris的上一次评级是在2023年9月13日提交的，所以你应该预计下一次评级将在2024年9月13日左右的某个时候公布。
Is the Analyst Rating Arteris (AIP) correct?
分析师对Arteris(AIP)的评级正确吗？
While ratings are subjective and will change, the latest Arteris (AIP) rating was a reiterated with a price target of $0.00 to $21.00. The current price Arteris (AIP) is trading at is $7.44, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Arteris(AIP)评级被重申，目标价在0.00美元至21.00美元之间。Arteris(AIP)目前的交易价格为7.44美元，在分析师的预测范围内。